ASH Data On CRS Helps Determine Where Anti-CD20 Bispecifics Fit Versus CAR-T

Leukemia
Data on several CD20-directed bispecific antibodies were presented at ASH • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Anticancer

More from Therapeutic Category